At Pentabase, we strive to help you with your needs. Contact us and one of our experts will get in touch with you shortly.
PentaBase’s CoviDetect™ diagnostic assay is a COVID-19 Multiplex Real-Time RT (Reverse transcriptase) qPCR assay for the detection of COVID-19. It enables analysis of three times as many samples with the use of the same standard laboratory equipment. This provides a reduced risk of false-positive results due to the improved target sensitivity and specificity compared with our standard PCR assays.
The CoviDetect™ assay allows the amplification of Viral N1 and N2 genes, and the human RNAse P internal control in a multiplex reaction with a single tube. The test capacity increases while the dependency on consumables is reduced.
The CoviDetect™ is designed and validated to be used on open Real-Time PCR platforms and equipment such as BaseTyper™ (our PCR instrument), LightCycler 480 II, ABI 7500™ and ViiA7™ for detecting FAM, HEX/VIC, and Cy5 channels.
- An innovative method to detect COVID-19 on real-time PCR
- Based on WHO and CDC guidelines
- Approved and validated in collaboration with Novo Nordisk and Rigshospitalet
- Delivered as either Dispense Ready (DR) or Ready-to-use (RTU) versions
Correlation between CoviDetect™ COVID-19 Multiplex RT-qPCR N1 and N2 assay Ct values and Comparator Method using SARS-CoV-2 positive leftover oropharyngeal swab specimens